Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
Actin A receptor type 2A (ACVR2A) is a single-pass serine/threonine transmembrane receptor encoded by the ACVR2A gene, distributed on plasma membrane surfaces across mesenchymal and epithelial somatic cell populations. Unlike soluble cytoplasmic kinase enzymes lacking lipid-binding helical segments, ACVR2A contains one transmembrane helix and extracellular ligand-binding domains dedicated to circulating activin growth factor recognition. It appears to operate as a membrane kinase transducer to relay extracellular growth factor signals into cytoplasmic kinase cascades under physiological tissue growth conditions. Unbalanced extracellular activin growth factor signaling easily disrupts ordered tissue proliferation without ACVR2A-mediated buffering, and ACVR2A establishes moderate signal equilibrium to stabilize growth factor gradient levels in diverse tissue microenvironments. Distinct tissue developmental stages generate unique pools of activin ligand molecules, requiring coordinated type 2 activin receptor networks to sustain balanced tissue proliferation within organ compartments. Membrane-localized ACVR2A may continuously interact with extracellular activin ligands to limit excessive growth signal accumulation and preserve tissue proliferation equilibrium. Conserved extracellular ligand-binding domains of ACVR2A support high-selectivity recognition of activin dimeric ligands at membrane surfaces, a structural feature that prevents non-specific growth factor cross-activation and disorganized tissue proliferation across mesenchymal tissue subtypes.
ACVR2A may mediate cytoplasmic serine/threonine kinase signaling cascades triggered by extracellular activin ligand binding. Sequence variants within the ACVR2A gene alter activin ligand binding affinity and correlate with disordered tissue proliferation states. No other type 2 activin receptor fully recapitulates ACVR2A's dual capacity for dimeric growth factor sensing and cytoplasmic kinase signal relay at plasma membranes. Variations in ACVR2A expression levels likely correspond to tissue proliferative regulatory status, rendering the receptor a suitable research target for TGF-beta superfamily receptor structural biology and growth factor signal analysis. ACVR2A localizes to plasma membrane outer surfaces to capture extracellular activin dimeric ligands without entering cytoplasmic organelle luminal compartments. Its integral membrane topology separates it from soluble cytoplasmic kinases, carrying dual potential roles in sustaining steady tissue growth factor gradients and mediating ordered cell proliferation cues. ACVR2A-coupled cytoplasmic kinase signaling may adjust intracellular growth regulatory messenger concentrations and modify cellular proliferative activity. Reduced functional ACVR2A elevates unregulated extracellular growth factor signal levels and weakens activin ligand response capacity, making ACVR2A a research subject for basic single-pass serine/threonine kinase receptor studies.
Fig. 1 Ribbon representation of human ACVR2A extracellular domain, marking key secondary-structure regions of the receptor.1
The biological functions of integral membrane ACVR2A type 2A activin receptor are focused on sustained dimeric activin ligand binding and cytoplasmic serine/threonine kinase signal cascade transmission:
Creative Biolabs offers purified ACVR2A membrane protein samples produced under unified preparation workflows, including full-length ACVR2A constructs and isolated extracellular activin ligand-binding domain variants. Truncated receptor fragments cannot support complete dimeric activin ligand recognition and cytoplasmic kinase signal coupling activity, while full-length constructs fit research focused on TGF-beta receptor-growth factor interaction and ligand-bound conformational analysis. All batches receive uniform quality screening. Functional assessments may only be performed on full-length membrane receptor under simulated lipid bilayer microenvironment setups. Consistent extracellular ligand-binding domain structural features are preserved across batches to support comparative laboratory analysis between experimental groups. Full-length ACVR2A membrane samples retain intact dimeric activin ligand-binding pocket conformation after standardized purification, which supports reliable detection of weak and transient activin-receptor binding events in comparative membrane functional analysis.
Not finding the Membrane Protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides cell research models with adjustable ACVR2A expression levels, suitable for structural observation of single-pass serine/threonine kinase receptors and research into dimeric activin growth factor ligand interaction processing. Sample assessment covers sustained target membrane expression detection and preliminary activin ligand-receptor interaction analysis, enabling side-by-side comparison of receptor conformational behavior under varying membrane expression abundances. These cell models can be paired with diverse laboratory analysis schemes to track shifts in activin ligand response efficiency alongside changing target membrane protein levels.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-ACVR2A recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for plasma membrane localization mapping and identification of dimeric activin ligand-receptor complexes. The antibody series works with common laboratory detection reagents to support multi-dimensional observation of target membrane distribution within tissue samples.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for ACVR2A research:
ACVR2A may act as an integral single-pass serine/threonine kinase transmembrane receptor and participate in transmembrane transmission of dimeric extracellular activin growth factor signals.
ACVR2A expression status may alter membrane activin ligand response capacity and intracellular cytoplasmic kinase messenger cascade output, serving as a key mediator of tissue cell proliferation regulatory biological processes.
No, all ACVR2A related products and services are strictly for research use only, and cannot be applied in clinical workflows. All material design and functional screening are optimized exclusively for basic laboratory research, without meeting clinical application criteria.
Offerings include full-length ACVR2A membrane protein, target-specific recombinant antibodies and tunable expression cell research models, supporting research on TGF-beta receptor-activin ligand binding and tissue proliferative signal transduction.
Laboratory analysis schemes may include dimeric activin growth factor ligand binding assays to assess its growth factor recognition capacity under simulated lipid bilayer environments.